References
- Padilla-Rivas GR, Delgado-Gallegos JL, Garza-Treviño G, Galan-Huerta KA, G-Buentello Z, Roacho-Pérez JA, et al. Association between mortality and cardiovascular diseases in the vulnerable Mexican population: a cross-sectional retrospective study of the COVID-19 pandemic. Front Public Health. 2022;10:
1008565 . DOI: 10.3389/fpubh.2022.1008565 - Schultz WM, Kelli HM, Lisko JC, Varghese T, Shen J, Sandesara P, et al. Socioeconomic status and cardiovascular outcomes: challenges and interventions. Circulation. 2018;137(20):2166–2178. DOI: 10.1161/CIRCULATIONAHA.117.029652
- World Health Organization. Cardiovascular diseases (CVDs). Accessed February 11, 2025.
https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) . - Instituto Nacional de Estadística y Geografía. Principales Causas de Mortalidad Por Residencia Habitual, Grupos de Edad y Sexo Del Fallecido. Consulta de Resultados: Tabulados Básicos. 2024. Accessed February 11, 2025. Available from:
https://www.inegi.org.mx/sistemas/olap/registros/vitales/mortalidad/tabulados/pc.asp?t=14&c=11817 . - Escamilla-Nuñez MC, Castro-Porras L, Romero-Martinez M, Zárate-Rojas E, Rojas-Martínez R. Detección, diagnóstico previo y tratamiento de enfermedades crónicas no transmisibles en adultos mexicanos. Ensanut 2022. Salud Publica Mex. 2023;65:s153–s162. DOI: 10.21149/14726
- Shamah-Levy T, Lazcano-Ponce E, Cuevas-Nasu L, Romero-Martínez M, Gaona-Pineda EB, Gómez-Acosta LM, et al. Encuesta Nacional de Salud y Nutrición Continua 2023. Resultados Nacionales. 2024. Accessed February 11, 2025. Available from:
https://ensanut.insp.mx/encuestas/ensanutcontinua2023/doctos/informes/ensanut_23_112024.pdf . - Al-Shudifat M, Sumra B, Kocherry C, Shamim H, Jhakri K, Khan S. Comparing glucagon-like peptide-1 receptor agonists to sodium-glucose cotransporter-2 inhibitors in heart failure with preserved ejection fraction: a systematic review. Cureus. 2025;17(2):
e78570 . DOI: 10.7759/cureus.78570 - Consejo Nacional de Evaluación de la Política de Desarrollo Social (CONEVAL). Informe de Evaluación de La Política de Desarrollo Social 2024. CONEVAL; 2025. Accessed January 19, 2026. Available from:
https://www.coneval.org.mx/EvaluacionDS/PP/CEIPP/Documents/Informes/IEPDS_2024.pdf . - Argumedo G, Cruz-Casarrubias CA, Bonvecchio-Arenas A, Jáuregui A, Saavedra-Romero A, Martínez-Montañez OG, et al. Hacia el diseño de Vida Saludable, un nuevo programa de estudios para la educación básica en México. Salud Publica Mex. 2023;65(1):82–92. DOI: 10.21149/14212
- Rivera Dommarco J. Obesidad en México: recomendaciones para una política de Estado. 1st ed. Mexico: Universidad Nacional Autónoma de México; 2012.
- Wilson PWF, Bozeman SR, Burton TM, Hoaglin DC, Ben-Joseph R, Pashos CL. Prediction of first events of coronary heart disease and stroke with consideration of adiposity. Circulation. 2008;118(2):124–130. DOI: 10.1161/CIRCULATIONAHA.108.772962
- Uddenberg ER, Safwan N, Saadedine M, Hurtado MD, Faubion SS, Shufelt CL. Menopause transition and cardiovascular disease risk. Maturitas. 2024;185:
107974 . DOI: 10.1016/j.maturitas.2024.107974 - Ebong IA, Quesada O, Fonkoue IT, Mattina D, Sullivan S, de Oliveira GMM, et al. The role of psychosocial stress on cardiovascular disease in women. J Am Coll Cardiol. 2024;84(3):298–314. DOI: 10.1016/j.jacc.2024.05.016
- NHS website for England. Cardiovascular disease. 2023. Accessed February 11, 2025. Available from:
https://www.nhs.uk/conditions/cardiovascular-disease/ . - Chobufo MD, Gayam V, Soluny J, Rahman EU, Enoru S, Foryoung JB, et al. Prevalence and control rates of hypertension in the USA: 2017–2018. Int J Cardiol Hypertens. 2020;6:
100044 . DOI: 10.1016/j.ijchy.2020.100044 - Romero-Martínez M, Shamah-Levy T, Vielma-Orozco E, Heredia-Hernández O, Mojica-Cuevas J, Cuevas-Nasu L, et al. Encuesta Nacional de Salud y Nutrición 2018–19: metodología y perspectivas. Salud Publica Mex. 2019;61(6):917–923. DOI: 10.21149/11095
- Hajifathalian K, Ueda P, Lu Y, Woodward M, Ahmadvand A, Aguilar-Salinas CA, et al. A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys. Lancet Diabetes Endocrinol. 2015;3(5):339–355. DOI: 10.1016/S2213-8587(15)00081-9
- Patel N, Mittal N, Wilkinson MJ, Taub PR. Unique features of dyslipidemia in women across a lifetime and a tailored approach to management. Am J Prev Cardiol. 2024;18:
100666 . DOI: 10.1016/j.ajpc.2024.100666 - Daviglus ML, Talavera GA, Avilés-Santa ML, Allison M, Cai J, Criqui MH, et al. Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the United States. JAMA. 2012;308(17):1775–1784. DOI: 10.1001/jama.2012.14517
- Lopez-Neyman SM, Davis K, Zohoori N, Broughton KS, Moore CE, Miketinas D. Racial disparities and prevalence of cardiovascular disease risk factors, cardiometabolic risk factors, and cardiovascular health metrics among US adults: NHANES 2011–2018. Sci Rep. 2022;12(1):
19475 . DOI: 10.1038/s41598-022-21878-x - Saito I, Iso H, Kokubo Y, Inoue M, Tsugane S. Body mass index, weight change and risk of stroke and stroke subtypes: the Japan Public Health Center-based prospective (JPHC) study. Int J Obes. 2011;35(2):283–291. DOI: 10.1038/ijo.2010.131
- Kurth T, Gaziano JM, Rexrode KM, Kase CS, Cook NR, Manson JE, et al. Prospective study of body mass index and risk of stroke in apparently healthy women. Circulation. 2005;111(15):1992–1998. DOI: 10.1161/01.CIR.0000161822.83163.B6
- Lu M, Ye W, Adami H-O, Weiderpass E. Prospective study of body size and risk for stroke amongst women below age 60. J Intern Med. 2006;260(5):442–450. DOI: 10.1111/j.1365-2796.2006.01706.x
- Piché ME, Tchernof A, Després JP. Obesity Phenotypes, Diabetes, and Cardiovascular Diseases. Circ Res. 2020;126(11):1477–1500. DOI: 10.1161/CIRCRESAHA.120.316101
- Möller-Leimkühler AM. Gender differences in cardiovascular disease and comorbid depression. Dialogues Clin Neurosci. 2007;9(1):71–83. DOI: 10.31887/DCNS.2007.9.1/ammoeller
- Nansseu JR, Kameni BS, Assah FK, Bigna JJ, Petnga S-J, Tounouga DN, et al. Prevalence of major cardiovascular disease risk factors among a group of sub-Saharan African young adults: a population-based cross-sectional study in Yaoundé, Cameroon. BMJ Open. 2019;9(10):
e029858 . DOI: 10.1136/bmjopen-2019-029858 - Manfrini O, Yoon J, van der Schaar M, Kedev S, Vavlukis M, Stankovic G, et al. Sex Differences in modifiable risk factors and severity of coronary artery disease. JAHA. 2020;9(19):
e017235 . DOI: 10.1161/JAHA.120.017235 - Olaiz-Fernández G, Rojas-Martinez R, Aguilar Salinas C. Diabetes mellitus en adultos mexicanos: resultados de la Encuesta Nacional de Salud 2000. Salu Pública Mex. 2007;49(3):
7 . DOI: 10.1590/S0036-36342007000900004 - Rojas-Martínez R, Basto-Abreu A, Aguilar-Salinas CA, Zárate-Rojas E, Villalpando S, Barrientos-Gutiérrez T. Prevalencia de diabetes por diagnóstico médico previo en México. Salud Publica Mex. 2018;60(3):
224 . DOI: 10.21149/8566 - Basto-Abreu A, Barrientos-Gutiérrez T, Rojas-Martínez R, Aguilar-Salinas CA, López-Olmedo N, De la Cruz-Góngora V, et al. Prevalencia de diabetes y descontrol glucémico en México: resultados de la Ensanut 2016. Salud Publica Mex. 2019;62(1):
50 . DOI: 10.21149/10752 - Reyes-García A, Basto-Abreu A, Reyes-Sánchez F, Stern D, Romero-Martínez M, Campos-Nonato I, et al. Prevalencia de diabetes y control glucémico en México, Ensanut 2021–2024. Salud Publica Mex. 2025;67(6):622–632. DOI: 10.21149/17286
- Huebschmann AG, Huxley RR, Kohrt WM, Zeitler P, Regensteiner JG, Reusch JEB. Sex differences in the burden of type 2 diabetes and cardiovascular risk across the life course. Diabetologia. 2019;62(10):1761–1772. DOI: 10.1007/s00125-019-4939-5
- De Ritter R, de Jong M, Vos RC, van der Kallen CJH, Sep SJS, Woodward M, et al. Sex differences in the risk of vascular disease associated with diabetes. Biol Sex Differ. 2020;11(1):
1 . DOI: 10.1186/s13293-019-0277-z - Rezaianzadeh A, Moftakhar L, Seif M, Johari MG, Hosseini SV, Dehghani SS. Incidence and risk factors of cardiovascular disease among population aged 40–70 years: a population-based cohort study in the South of Iran. Trop Med Health. 2023;51(1):
35 . DOI: 10.1186/s41182-023-00527-7 - Rojas-Martínez R, Escamilla-Núñez C, Castro-Porras L, Basto-Abreu A, Barrientos-Gutiérrez T, Romero-Martínez M, et al. Tamizaje, prevalencia, diagnóstico previo, tratamiento y control de hipertensión, hipercolesterolemia y diabetes en adultos mexicanos. Ensanut 2022. Salud Publica Mex. 2023;65(6):685–696. DOI: 10.21149/15060
- Manrique-Acevedo C, Chinnakotla B, Padilla J, Martinez-Lemus LA, Gozal D. Obesity and cardiovascular disease in women. Int J Obes. 2020;44(6):1210–1226. DOI: 10.1038/s41366-020-0548-0
- Wilkins JT, Ning H, Berry J, Zhao L, Dyer AR, Lloyd-Jones DM. Lifetime risk and years lived free of total cardiovascular disease. JAMA. 2012;308(17):
1795 . DOI: 10.1001/jama.2012.14312 - Secretaría de Salud de México. Programa de Acción Específico: Prevención y Control de la Obesidad y Riesgo Cardiovascular 2013–2018 [Internet]. 2014. Accessed June 21, 2025. Available from:
https://www.gob.mx/cms/uploads/attachment/file/37677/PAE_PrevencionControlObesidadRiesgoCardiovascular2013_2018.pdf . - Irazola V, Prado C, Rosende A, Flood D, Tsuyuki R, Ojeda CN, et al. Expanding team-based care for hypertension and cardiovascular risk management with HEARTS in the Americas. Revista Panamericana de Salud Pública. 2025;49:
1 . DOI: 10.26633/RPSP.2025.43 - Tecson KM, Kluger AY, Cassidy-Bushrow AE, Jefferson CR, VanWormer JJ, McCullough PA, et al. Usefulness of statins as secondary prevention against recurrent and terminal major adverse cardiovascular events. Am J Cardiol. 2022;176:37–42. DOI: 10.1016/j.amjcard.2022.04.018
- Bhupathiraju SN, Hu FB. Epidemiology of obesity and diabetes and their cardiovascular complications. Circ Res. 2016;118(11):1723–1735. DOI: 10.1161/CIRCRESAHA.115.306825
- Kaminsky LA, German C, Imboden M, Ozemek C, Peterman JE, Brubaker PH. The importance of healthy lifestyle behaviors in the prevention of cardiovascular disease. Prog Cardiovasc Dis. 2022;70:8–15. DOI: 10.1016/j.pcad.2021.12.001
- Fajardo-Dolci GE, Vicuña-De Anda FJ, Ortiz-Vázquez P, Olaiz-Fernández G. The burden of cardiovascular disease in Mexico 1990–2021. Summary of the Global Burden of Disease 2021 study. GMM. 2024;159(6):
13424 . DOI: 10.24875/GMM.M24000837 - Regensteiner JG, Reusch JEB. Sex differences in cardiovascular consequences of hypertension, obesity, and diabetes. J Am Coll Cardiol. 2022;79(15):1492–1505. DOI: 10.1016/j.jacc.2022.02.010
- Huebschmann AG, Huxley RR, Kohrt WM, Zeitler P, Regensteiner JG, Reusch JEB. Sex differences in the burden of type 2 diabetes and cardiovascular risk across the life course. Diabetologia. 2019;62(10):1761–1772. DOI: 10.1007/s00125-019-4939-5
- Lichtman JH, Leifheit EC, Safdar B, Bao H, Krumholz HM, Lorenze NP, et al. Sex differences in the presentation and perception of symptoms among young patients with myocardial infarction: evidence from the VIRGO study (Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients). Circulation. 2018;137(8):781–790. DOI: 10.1161/CIRCULATIONAHA.117.031650
- Huebschmann A, Regensteiner J. Women are at a higher risk of dying from heart disease – in part because doctors don’t take major sex and gender differences into account. The Conversation. DOI: 10.64628/AAI.3kpecmhta
- Davis SR, Baber RJ. Treating menopause — MHT and beyond. Nat Rev Endocrinol. 2022;18(8):490–502. DOI: 10.1038/s41574-022-00685-4
- Kuryłowicz A. Estrogens in adipose tissue physiology and obesity-related dysfunction. Biomedicines. 2023;11(3):
690 . DOI: 10.3390/biomedicines11030690 - Ko SH, Kim HS. Menopause-associated lipid metabolic disorders and foods beneficial for postmenopausal women. Nutrients. 2020;12(1):
202 . DOI: 10.3390/nu12010202 - Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol. J Am Coll Cardiol. 2019;73(24):e285–e350. DOI: 10.1016/j.jacc.2018.11.003
- Stroke Journal Report. Major Cardiovascular Risk Factor Rates Are High in the U.S. Hispanic/Latino Population. American Heart Association; 2021. Accessed June 6, 2025. Available from:
https://newsroom.heart.org/news/major-cardiovascular-risk-factor-rates-are-high-in-the-u-s-hispaniclatino-population .